Equity Details
Price & Market Data
Price: $28.51
Daily Change: +$0.99 / 3.47%
Daily Range: $26.68 - $28.51
Market Cap: $527,582,432
Daily Volume: 237,572
Performance Metrics
1 Week: -4.77%
1 Month: -6.68%
3 Months: 32.83%
6 Months: 44.72%
1 Year: 35.01%
YTD: 34.04%
About Tectonic Therapeutic, Inc. (TECX)
Get insights into Tectonic Therapeutic, Inc. (TECX)'s financial health. With a price of 28.51, the stock shows a +$0.99 / 3.47% daily change. Its market cap is 527,582,432. Detailed performance for 1-month (-6.68%) and 52-week (35.01%) periods are crucial.
Company Details
Employees: 60
Sector: Commercial services
Industry: Miscellaneous commercial services
Country: United States
Details
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.